Jump to content

Do you want up to date information about Scleroderma? Check out our Medical pages at www.sclero.org for all your Scleroderma questions!


Development Of An Activity Index For Localized Scleroderma (Morphea).

  • Please log in to reply
No replies to this topic

#1 Joelf


    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,547 posts
  • Location:West Sussex

Posted 02 September 2011 - 11:43 PM

Development Of An Activity Index For Localized Scleroderma (Morphea).

This pilot study provided evidence that a combined therapy of methotrexate and low dose steroids may be effective to treat morphea. Further studies on larger cohort of patients are needed to validate this activity index. E. Lanciano. EULAR 2011 FR10406. Ann rheumatologist Dis 2011;70(Suppl3):481. (Also see: Morphea)

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.

Jo Frowde
ISN Assistant Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)